2015742
`
`August 14, 2017
`
`THIS IS TO CERTIFY THAT ANNEXED IS A TRUE COPY FROM THE
`RECORDS OF THIS OFFICE OF THE FILE WRAPPER AND CONTENTS
`OF:
`
`APPLICATION NUMBER: 15/180,439
`FILING DATE: June 13, 2016
`PATENT NUMBER: 9644170
`ISSUE DATE: May 09, 2017
`
`RIMFROST EXHIBIT 1063 page 0001
`
`

`

`DocCode — SCORE
`
`SCORE Placeholder Sheetfor IFW Content
`
`Application Number: 15180439
`
`Document Date: 06/13/2016
`
`The presence ofthis form in the IFW record indicates that the following documenttype wasreceived
`in electronic format on the date identified above. This content is stored in the SCORE database.
`
`Since this was an electronic submission, there is no physical artifact folder, no artifact folder is
`recorded in PALM, and no paper documents or physical media exist. The TIFF images in the IFW
`record were created from the original documents that are stored in SCORE.
`
`Drawing
`
`At the time of documententry (noted above):
`e USPTO employees may access SCORE content via eDAN using the Supplemental Content
`tab, or via the SCORE webpage.
`e External customers may access SCORE content via PAIR using the Supplemental Content
`tab.
`
`Form Revision Date: August 26, 2013
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0002
`
`page 0002
`
`

`

`Doc Code: TRACK1.REQ
`DocumentDescription: TrackOne Request
`
`PTO/AIA/424 (04-14)
`
`CERTIFICATION AND REQUESTFOR PRIORITIZED EXAMINATION
`UNDER 37 CFR 1.102(e) (Page 1 of 1)
`
`Inge Bruheim[tromeerieTO
`
`BIOEFFECTIVE KRILL OIL COMPOSITIONS
`
`APPLICANT HEREBYCERTIFIES THE FOLLOWING AND REQUESTSPRIORITIZED EXAMINATION FOR
`THE ABOVE-IDENTIFIED APPLICATION.
`
`forms are submitted.
`
`A request for continued examination has beenfiled with, or prior to, this form.
`If the application is a utility application, this certification and requestis being filed via EFS-Web.
`iii. The application is an original nonprovisionalutility application filed under 35 U.S.C. 111(a), or is
`a national stage entry under 35 U.S.C. 3771.
`iv. This certification and requestis being filed prior to the mailing of a first Office action responsive
`to the request for continued examination.
`No prior requestfor continued examination has been granted prioritized examination status
`under 37 CFR 1.102(e)(2).
`
`1. The processing fee set forth in 37 CFR 1.17(i)(1) and the prioritized examination fee set forth in
`37 CFR 1.17(c) have been filed with the request. The publication fee requirementis met
`becausethat fee, set forth in 37 CFR 1.18(d), is currently $0. The basic filing fee, search fee,
`and examination fee arefiled with the request or have been already been paid.
`| understand
`that any required excess claims fees or application size fee must be paid for the application.
`
`| understand that the application may not contain, or be amendedto contain, more than four
`independentclaims, more than thirty total claims, or any multiple dependent claims, and that
`any request for an extension of time will cause an outstanding Track | request to be dismissed.
`
`3. The applicable box is checked below:
`
`Original Application (Track One)
`
`- Prioritized Examination under § 1.102(e)(1
`
`i.
`
`(a) The application is an original nonprovisional utility application filed under 35 U.S.C. 111(a).
`This certification and requestis being filed with the utility application via EFS-Web.
`---OR---
`(b) The application is an original nonprovisional plant application filed under 35 U.S.C. 111(a).
`This certification and requestis being filed with the plant application in paper.
`
`An executed inventor’s oath or declaration under 37 CFR 1.63 or 37 CFR 1.64 for each
`inventor, or the application data sheet meeting the conditions specified in 37 CFR 1.53(f)(3)(i) is
`filed with the application.
`
`Request for Continued Examination - Prioritized Examination under § 1.102(e)(2)
`
`signature/J- Mitchell Jones/
`Name
`J. Mitchell Jones
`(Print/Typed)
`
`patevUNe 13, 2016
`Practitioner
`44174
`Registration Number
`
`This form must be signed in accordance with 37 CFR 1.33. See 37 CFR 1.4(d) for signature requirements and certifications.
`Note:
`Submit multiple forms if more than one signature is required.”
`
`*Total of 1
`
`RIMFROST EXHIBIT 1063
`
`page 0003
`
`RIMFROST EXHIBIT 1063 page 0003
`
`

`

`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your
`submission of the attached form related to a patent application or patent. Accordingly, pursuant to the requirements of
`the Act, please be advised that: (1) the general authority for the collection of this information is 35 U.S.C. 2(b)(2); (2)
`furnishing of the information solicited is voluntary; and (3) the principal purpose for which the information is used by the
`U.S. Patent and Trademark Office is to process and/or examine your submission related to a patent application or
`patent.
`If you do not furnish the requested information, the U.S. Patent and Trademark Office may not be able to
`process and/or examine your submission, which may result in termination of proceedings or abandonmentof the
`application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1. The information on this form will be treated confidentially to the extent allowed under the Freedom of
`Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from this system of records may
`be disclosed to the Departmentof Justice to determine whether disclosure of these records is required by the
`Freedom ofInformation Act.
`A record from this system of records maybe disclosed, as a routine use, in the course of presenting evidence
`to a court, magistrate, or administrative tribunal, including disclosures to opposing counsel in the course of
`settlement negotiations.
`A record in this system of records maybe disclosed, as a routine use, to a Member of Congress submitting a
`request involving an individual, to whom the record pertains, when the individual has requested assistance from
`the Member with respect to the subject matter of the record.
`A record in this system of records maybe disclosed, as a routine use, to a contractor of the Agency having
`needfor the information in order to perform a contract. Recipients of information shall be required to comply
`with the requirements of the Privacy Act of 1974, as amended, pursuantto 5 U.S.C. 552a(m).
`A record related to an International Application filed under the Patent Cooperation Treaty in this system of
`records maybe disclosed, as a routine use, to the International Bureau of the World Intellectual Property
`Organization, pursuant to the Patent Cooperation Treaty.
`A record in this system of records maybe disclosed, as a routine use, to another federal agency for purposes
`of National Security review (35 U.S.C. 181) and for review pursuantto the Atomic Energy Act (42 U.S.C.
`218(c)).
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General
`Services, or his/her designee, during an inspection of records conducted by GSAaspart of that agency’s
`responsibility to recommend improvements in records managementpractices and programs, under authority of
`44 U.S.C. 2904 and 2906. Such disclosure shall be made in accordance with the GSA regulations governing
`inspection of records for this purpose, and any other relevant (/.e., GSA or Commerce) directive. Such
`disclosure shall not be used to make determinations about individuals.
`A record from this system of records maybe disclosed, as a routine use, to the public after either publication of
`the application pursuant to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a
`record may be disclosed, subject to the limitations of 37 CFR 1.14, as a routine use, to the public if the record
`wasfiled in an application which became abandonedor in which the proceedings were terminated and which
`application is referenced by either a published application, an application open to public inspection or an issued
`patent.
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law
`enforcement agency, if the USPTO becomesawareof a violation or potential violation of law or regulation.
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0004
`
`page 0004
`
`

`

`PTO/AIA14 (11-15)
`Approved for use through 04/30/2017. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
`
` .
`
`
`. Attorney Docket Number|AKBM-14409/US-13/CON
`
`Application Data Sheet 37 CFR 1.76
`
`
`
`
`
`
`
`Application Number
`
`Title of Invention|BIOEFFECTIVE KRILL OIL COMPOSITIONS
`
`The application data sheetis part of the provisional or nonprovisional application for whichit is being submitted. The following form contains the
`bibliographic data arranged in a format specified by the United States Patent and Trademark Office as outlined in 37 CFR 1.76.
`This document may be completed electronically and submitted to the Office in electronic format using the Electronic Filing System (EFS) or the
`document may be printed and included in a paperfiled application.
`
`Secrecy Order 37 CFR 5.2:
`
`Oo Portions or all of the application associated with this Application Data Sheet may fall under a Secrecy Order pursuant to
`37 CFR 5.2 (Paperfilers only. Applications that fall under Secrecy Order may not be filed electronically.)
`
`Inventor Information:
`
`Inventor
`Legal Name
`
`{1
`
`Remove
`
` 0 i
`
`ResidenceInformation (Select One)
`
`US Residency
`
`e@ Non US Residency
`
`Active US Military Service
`
`
`
`
`Mailing Address of Inventor:
`
`
`Address 1
`
`Storhagen 24
`
`Address 2
`city [PoweSS—~=SYStatelProvince |
`
`
`Postal Code Bo«dCountry|FO
`Inventor
`2
`Legal Name
`
`
`
` Prefix} Given Name
`Middle Name
`Family Name
`
`ResidenceInformation (Select One)
`US Residency
`@) Non US Residency
`Active US Military Service
`
`city[Been———_—id Country of Residence fod
`
`
`
`
`
`
`Mailing Addressof Inventor:
`Address 1
`I antoftasen 27 A
`
`Address 2
`
`
`
`city [pewenSSCS_StatelProvince
`
`Inventor
`Legal Name
`
`EFS Web 2.2.12
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0005
`
`page 0005
`
`

`

`PTO/AIA14 (11-15)
`Approved for use through 04/30/2017. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`
` AKBM-14409/US-13/CON
`
`Application Data Sheet 37 CFR 1.76
`
`
`
`
`
`
`BIOEFFECTIVE KRILL OIL COMPOSITIONS
`Title of Invention
`
`
`Attorney Docket Number
`
`Application Number
`
`Family Name
`
`ResidenceInformation (Select One)
`
`US Residency
`
`@) Non US Residency
`
`Active US Military Service
`
`
`Mailing Address of Inventor:
`
`Address 1
`
`
`
`
`Address 2
`
`
`Pee_~*YStaterProvince
`Postal Code
`
`Inventor Information blocks may be
`Inventors Must Be Listed - Additional
`All
`Add
`
`generated within this form by selecting the Add button.
`
`CorrespondenceInformation:
`
`Enter either Customer Numberor complete the Correspondence Information section below.
`For further information see 37 CFR 1.33(a).
`
`|] An Address is being provided for the correspondence Information of this application.
`
`Customer Number
`
`Email Address
`
`dockeling@casimirjones.com
`
`Add Email
`
`Application Information:
`
`
`Title of the Invention
`
`
`
`
`
`[feaw-iaa0oUSCON[SmallEntityStatusClaimed(]
`Attorney Docket Number
`
`
`[PessinaCCOCS*@CS
`
`Application Type
`
`
`
`
`biy
`
`Subject Matter
`
`
`
`
`Te|StesestedFigureorPubiationfamTT
`
`Total Number of Drawing Sheets (if any)
`Filing By Reference:
`
`
`
`
`Only complete this section whenfiling an application by reference under 35 U.S.C. 111(c) and 37 CFR 1.57{a). Do not complete this section if
`application papers including a specification and any drawings are beingfiled. Any domestic benefit or foreign priority information must be
`provided in the appropriate section(s) below (i.e., "Domestic Benefit/National Stage Information” and “Foreign Priority Information”).
`
`
`
`
`
`
`
`
`
`
`
`For the purposesofa filing date under 37 CFR 1.53(b), the description and any drawings of the present application are replaced by this
`reference to the previously filed application, subject to conditions and requirements of 37 CFR 1.57(a}.
`
`Application numberof the previously
`filed application
`
`Filing date (YYYY-MM-DD)
`
`Intellectual Property Authority or Country
`
`i
`
`EFS Web 2.2.12
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0006
`
`page 0006
`
`

`

`PTO/AIA14 (11-15)
`Approved for use through 04/30/2017. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`
`Attorney Docket Number|AKBM-14409/US-13/CON
`
`
`Application Data Sheet 37 CFR 1.76
`
`
`
`
`
`BIOEFFECTIVE KRILL OIL COMPOSITIONS
`Title of Invention
`
`
`Application Number
`
`Publication Information:
`
`[_] Request Early Publication (Fee required at time of Request 37 CFR 1.219)
`
`Cl]
`
`Request Not to Publish. | hereby requestthat the attached application not be published under
`35 U.S.C. 122(b) and certify that the invention disclosed in the attached application has not and will not be the
`subject of an application filed in another country, or under a multilateral international agreement, that requires
`publication at eighteen monthsafterfiling.
`
`
`
`
`
`Representative Information:
`
`Representative information should be provided for all practitioners having a power of attorney in the application. Providing
`this information in the Application Data Sheet does not constitute a power of attorney in the application (see 37 CFR 1.32).
`Either enter Customer Number or complete the Representative Name section below.If both sections are completed the customer
`Numberwill be used for the Representative Information during processing.
`
`
`
`©) Limited Recognition (37 CFR 11.9) Customer Number
`
`Please Select One:
`
`e@ Customer Number
`| 72960
`
`US Patent Practitioner
`
`Domestic Benefit/National Stage Information:
`This section allows for the applicant to either claim benefit under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c) or indicate
`National Stage entry from a PCT application. Providing benefit claim information in the Application Data Sheet constitutes
`the specific reference required by 35 U.S.C. 119(e) or 120, and 37 CFR 1.78.
`Whenreferring to the current application, please leave the “Application Number’field blank.
`Prior Application Status [Pending
`
`
`
`
`
`Filing or 371(c) Date
`Application Number
`Continuity Type
`Prior Application Number
`(YYYY-MM-DD)
`
`P|emtruatonorLY t40z0re2 _pots-08.06
`
`
`Prior Application Status|Patented
`Application
`.
`Prior Application
`Filing Date
`Issue Date
`Number
`Continuity Type
`(YYYY-MM-DD)
`Patent Number
`(YYYY-MM-DD)
`PriorApplication Statusel
`
`H4020162|Continuationof|| [12057775 |008-03-28 |pos43e8 |b015-05-19
`
`
`
`Filing or 371(c) Date
`Application Number
`Continuity Type
`Prior Application Number
`(YYYY-MM-DD)
`pee|Peesomefern
`Prior Application Status
`
`Filing or 371(c) Date
`Application Number
`Continuity Type
`Prior Application Number
`(YYYY-MM-DD)
`RIMFROST EXHIBIT 1063 page 0007
`
`
`
`12057775|BPlaimsbenefitprovisionalof[+ 6097505ERIMFROST EXHIBIT 1063 page 0007
`
`
`
`EFS Web 2.2.12
`
`
`
`

`

`PTO/AIA14 (11-15)
`Approved for use through 04/30/2017. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`
`Attorney Docket Number|AKBM-14409/US-13/CON
`
`
`Application Data Sheet 37 CFR 1.76
`
`
`
`
`
`BIOEFFECTIVE KRILL OIL COMPOSITIONS
`Title of Invention
`
`Prior Application Status Expired
`
`Application Number
`
`Application Number
`2057775
`
`Continuity Type
`| laims benefit of provisional
`
`Prior Application Number
`+ 60983446
`
`Prior Application Number
`Continuity Type
`Application Number
`-| 61024072
`| laims benefit of provisional
`2057775
`Additional Domestic Benefit/National Stage Data may be generated within this form
`by selecting the Add button.
`
`Filing or 371(c) Date
`(YYYY-MM-DD)
`2007-10-29
`
`Filing or 371(c) Date
`(YYYY-MM-DD)
`PO08-01-28
`Add
`
`
`
`
`
`
`
`Foreign Priority Information:
`
`This section allows for the applicant to claim priority to a foreign application. Providing this information in the application data sheet
`constitutes the claim for priority as required by 35 U.S.C. 119(b) and 37 CFR 1.55. Whenpriority is claimed to a foreign application
`thatis eligible for retrieval under the priority document exchange program (PDX)! the information will be used by the Office to
`automatically attempt retrieval pursuant to 37 CFR 1.55{i)(1) and (2). Under the PDX program, applicant bears the ultimate
`responsibility for ensuring that a copy of the foreign application is received by the Office from the participating foreign intellectual
`
`property office, or a certified copy of the foreign priority application is filed, within the time period specified in 37 CFR 1.55(g){1).
`
`Filing Date (YYYY-MM-DD)
`Country!
`Application Number
`
`Additional Foreign Priority Data may be generated within this form by selecting the
`Add button.
`
`Remove
`Access Code! (if applicable)
`
`Add
`
`Statement under 37 CFR 1.55 or 1.78 for AIA (First Inventor to File) Transition
`Applications
`
`This application (1) claims priority to or the benefit of an application filed before March 16, 2013 and (2) also
`contains, or contained at any time, a claim to a claimed invention that has an effective filing date on or after March
`[] 16, 2013.
`NOTE: By providing this statement under 37 CFR 1.55 or 1.78,this application, with a filing date on or after March
`
`16, 2013, will be examined underthefirst inventorto file provisions of the AIA.
`
`EFS Web 2.2.12
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0008
`
`page 0008
`
`

`

`PTO/AIA14 (11-15)
`Approved for use through 04/30/2017. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`cat
`Application Data Sheet 37 CFR 1.76
`
`Title of Invention
`
`BIOEFFECTIVE KRILL OIL COMPOSITIONS
`
`
`
`Authorization or Opt-Out of Authorization to Permit Access:
`
`Whenthis Application Data Sheet is properly signed and filed with the application, applicant has provided written
`authority to permit a participating foreign intellectual property (IP) office access to the instant application-as-filed (see
`paragraph A in subsection 1 below) and the European Patent Office (EPO) access to any search results from the instant
`application (See paragraph B in subsection 1 below).
`
`Should applicant choose not to provide an authorization identified in subsection 1 below, applicant must opt-out of the
`authorization by checking the corresponding box A or B or both in subsection 2 below.
`
`NOTE: This section of the Application Data Sheet is ONLY reviewed and processed with the INITIALfiling of an
`application. After the initial filing of an application, an Application Data Sheet cannot be used to provide or rescind
`authorization for access by a foreign IP office(s).
`Instead, Form PTO/SB/39 or PTO/SB/69 must be used as appropriate.
`
`1. Authorization to Permit Access by a Foreign Intellectual Property Office(s)
`
`
`
`
`
`A. Priority Document Exchange (PDX)- Unless box A in subsection 2 (opt-out of authorization) is checked, the
`undersigned hereby grants the USPTO authority to provide the European Patent Office (EPO), the Japan Patent Office
`(JPO), the Korean Intellectual Property Office (KIP©), the State Intellectual Property Office of the People’s Republic of
`China (SIPO), the World Intellectual Property Organization (WIPO), and any other foreign intellectual property office
`participating with the USPTOin a bilateral or multilateral priority document exchange agreementin which a foreign
`application claiming priority to the instant patent application is filed, access to: (1) the instant patent application-as-filed
`andits related bibliographic data, (2) any foreign or domestic application to which priority or benefit is claimed by the
`instant application and its related bibliographic data, and (3) the date of filing of this Authorization. See 37 CFR 1.14(h)
`(1).
`
`B. Search Results from U.S. Application to EPO - Unless box B in subsection 2 (opt-out of authorization) is checked,
`the undersigned hereby grants the USPTO authority to provide the EPO accessto the bibliographic data and search
`results from the instant patent application when a European patent application claiming priority to the instant patent
`applicationis filed. See 37 CFR 1.14(h)(2).
`
`The applicant is reminded that the EPO’s Rule 141(1) EPC (European Patent Convention} requires applicants to submit a
`copy of search results from the instant application without delay in a European patent application that claims priority to
`the instant application.
`
`2. Opt-Out of Authorizations to Permit Access by a Foreign Intellectual Property Office(s)}
`
`[|
`
`A. Applicant DOES NOT authorize the USPTOto permit a participating foreign IP office access to the instant
`application-as-filed.
`If this box is checked, the USPTOwill not be providing a participating foreign IP office with
`any documents andinformation identified in subsection 1A above.
`
`B. Applicant DOES NOTauthorize the USPTOto transmit to the EPO any search results from the instant patent
`|] application. If this box is checked, the USPTO will not be providing the EPO with search results from the instant
`application.
`NOTE: Oncethe application has published or is otherwise publicly available, the USPTO may provide accessto the
`application in accordance with 37 CFR 1.14.
`
`EFS Web 2.2.12
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0009
`
`page 0009
`
`

`

`PTO/AIA14 (11-15)
`Approved for use through 04/30/2017. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`ee Attorney Docket Number|AKBM-14409/US-13/CON
`
`Application Data Sheet 37 CFR 1.76
`—
`
`Title of Invention
`
`BIOEFFECTIVE KRILL OIL COMPOSITIONS
`
`
`
`Applicant Information:
`
`Providing assignment information in this section does not substitute for compliance with any requirementof part 3 of Title 37 of CFR
`to have an assignment recorded by the Office.
`
`{1
`Applicant
`If the applicant is the inventor (or the remaining joint inventor or inventors under 37 CFR 1.45), this section should not be completed.
`The information to be provided in this section is the name and addressof the legal representative whois the applicant under 37 CFR
`1.43; or the name and addressof the assignee, person to whom the inventor is under an obligation to assign the invention, or person
`who otherwise showssufficient proprietary interest in the matter who is the applicant under 37 CFR 1.46. If the applicantis an
`applicant under 37 CFR 1.46 (assignee, person to whem theinventoris obligated to assign, or person who otherwise showssufficient
`proprietary interest) together with one or morejoint inventors, then the joint inventor or inventors who are also the applicant should be
`identified in this section.
`
`
`Clear
`
`@ Assignee
`
`
`
`Legal Representative under 35 U.S.C. 117
`
`Joint Inventor
`
`Person who showssufficient proprietary interest
`Person to whom the inventoris obligated to assign.
`
`lf applicant is the legal representative, indicate the authority to file the patent application, the inventor is:
`
`Nameof the Deceased or Legally Incapacitated Inventor:Po
`If the Applicant is an Organization check here.
`Xx]
`
`Organization Name
`
`i AKER BIOMARINE ANTARCTIC AS
`
`Mailing Address Information For Applicant:
`
`
`
`
`
`|
`Address 2
`||
`[Pansins_—*d StaterProvince
`city
`country [PO SSSSSCSCSCSCSCSC~*@di(tal ode|fH
`SL |
`
`Email Address
`
`
`Additional Applicant Data may be generated within this form by selecting the Add button.
`
`Add
`
`Assignee Information including Non-Applicant Assignee Information:
`
`Providing assignment information in this section does not substitute for compliance with any requirement of part 3 of Title
`
`37 of CFR to have an assignment recorded by the Office.
`
`EFS Web 2.2.12
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0010
`
`page 0010
`
`

`

`Complete this section if assignee information, including non-applicant assignee information, is desired to be included on the patent
`application publication. An assignee-applicant identified in the "Applicant Information” section will appear on the patent application
`publication as an applicant. For an assignee-applicant, complete this section onlyif identification as an assigneeis also desired on the
`patent application publication.
`Remove
`
`
`
`If the Assignee or Non-Applicant Assignee is an Organization check here. [|
`
` Prefix
`
`Mailing Address Information For Assignee including Non-Applicant Assignee:
`
`Address 2
`city
`county’
`
`i
`[id Siateirovincs [TS
`[[id stlcoce
`
`Email Address
`
`Additional Assignee or Non-Applicant Assignee Data may be generated within this form by
`selecting the Add button.
`
`Add
`
`
`
`
`
`
`
`PTO/AIA14 (11-15)
`Approved for use through 04/30/2017. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`
`Attorney Docket Number|AKBM-14409/US-13/CON
`
`
`Application Data Sheet 37 CFR 1.76
`
`
`
`
`
`BIOEFFECTIVE KRILL OIL COMPOSITIONS
`Title of Invention
`
`
`Application Number
`
`Assignee
`
`(1
`
`Signature:
`NOTE: This Application Data Sheet must be signed in accordance with 37 CFR 1.33(b). However,if this Application
`Data Sheet is submitted with the INITIALfiling of the application and either box A or B is not checked in
`subsection 2 of the “Authorization or Opt-Out of Authorization to Permit Access”section, then this form must
`also be signed in accordance with 37 CFR 1.14(c).
`
`This Application Data Sheet must be signed by a patent practitioner if one or more of the applicants is a juristic
`entity (€.g., corporation or association). If the applicant is two or more joint inventors, this form must be signed by a
`patent practitioner, all joint inventors who are the applicant, or one or more joint inventor-applicants who have been given
`powerof attorney (e.g., see USPTO Form PTO/AIA/81) on behalf of all joint inventor-applicants.
`See 37 CFR 1.4(d) for the manner of making signatures and certifications.
`
`
`Signature
`|/J. Mitchell Jones/
`Date (YYYY-MM-DD)|
`(2016-06-13
`
`
`
`First Name
`. Mitchell
`Last Name
`ones
`Registration Number
`174
`
`Additional Signature may be generated within this form by selecting the Add button.
`
`Add
`
`EFS Web 2.2.12
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0011
`
`page 0011
`
`

`

`PTO/AIA14 (11-15)
`Approved for use through 04/30/2017. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`ee Attorney Docket Number|AKBM-14409/US-13/CON
`
`Application Data Sheet 37 CFR 1.76
`
`— Title of Invention
`
`BIOEFFECTIVE KRILL OIL COMPOSITIONS
`
`This collection of information is required by 37 CFR 1.76. The information is required te obtain or retain a benefit by the public which
`is to file (and by the USPTOto process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This
`collection is estimated to take 23 minutes to complete, including gathering, preparing, and submitting the completed application data
`sheet form to the USPTO. Timewill vary depending upon the individual case. Any comments on the amount of time you require to
`complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
`Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR
`COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissionerfor Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`EFS Web 2.2.12
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0012
`
`page 0012
`
`

`

`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission of the attached form related to a patent
`application or patent. Accordingly, pursuant to the requirements of the Act, please be advised that: (1) the general authority for the collection of this information
`is 35 U.S.C. 2(b) (2); (2) furnishing of the information solicited is voluntary; and (3) the principal purpose for which the information is used by the U.S. Patent and
`Trademark Office is to process and/or examine your submission related to a patent application or patent. If you do not furnish the requested information, the U.S.
`Patent and Trademark Office may not be able to process and/or examine your submission, which mayresult in termination of proceedings or abandonmentof
`the application or expiration of the patent.
`
`
`
` page 0013
`
`Theinformation provided by you in this form will be subject to the following routine uses:
`
`1.
`
`2.
`
`3
`
`The information cn this form will be treated confidentially to the extent allowed under the Freedom ofInformation Act (5 U.S.C. 552) and the Privacy
`Act (5 U.S.C. 552a). Records from this system of records may be disclosed to the Departmentof Justice to determine whether the Freedom of
`Information Act requires disclosure of these records.
`
`Arecord from this system of records may be disclosed, as a routine use, in the course of presenting evidence to a court, magistrate, or administrative
`tribunal, including disclosures to opposing counselin the course of settlement negotiations.
`
`Areécord in this system of records may be disclosed,as a routine use, to a Member of Congress submitting a request involving an individual, to whom
`the record pertains, when the individual has requested assistance from the Memberwith respect to the subject matter of the record.
`
`4. Arecordin this system of records may be disclosed,as a routine use, to a contractor of the Agency having need for the information in order to perform
`a contract. Recipients of information shall be required to comply with the requirements of the Privacy Act of 1974, as amended, pursuant to 5 U.S.C.
`552a(m).
`
`5. Arecord related to an International Application filed under the Patent Cooperation Treaty in this system of records may be disclosed, as a routine use,
`to the Internaticnal Bureau of the World Intellectual Property Organization, pursuant to the Patent CooperationTreaty.
`
`6. Arecord in this system of records may be disclosed, as a routine use, to another federal agency for purposes of National Security review (35 U.S.C. 181}
`and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).
`
`7. Arecord from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or his/her designee, during an
`inspection of records conducted by GSAas part of that agency's responsibility to recommend improvements in records managementpractices and
`programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall be made in accordance with the GSA regulations governing inspection of
`recordsfor this purpose, and any other relevant(i.e., GSA or Commerce) directive. Such disclosure shall not be used tc make determinations about
`individuals.
`
`8. Arecord from this system of records may be disclosed,as a routine use, to the public after either publication of the application pursuant to 35 U.S.C.
`122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subjectto the limitations of 37 CFR 1.14, as a routine use,
`te the public if the record wasfiled in an application which became abandoned cr in which the proceedings were terminated and which application is
`referenced by either a published application, an application open to public inspections or an issued patent.
`
`9. Arecord from this system of records may be disclosed,as a routine use, to a Federal, State, or local law enforcement agency,if the USPTO becomes
`awareof a violation or potential violation of law or regulation.
`
`EFS Web 2.2.12
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0013
`
`

`

`
`
`
`
`
`
`PTCVALAIOT (G6-12)
`Approved faruse through O¢/3 1/2044. OMB G684-0032
`US. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paoerwork Reduction Act of 1665, no persons are requi